Park Square has placed Jeffrey Goldberg as Chief Executive Officer and Director of Immunitas Therapeutics.
{
Immunitas Therapeutics (“Immunitas”), an innovative single cell genomics discovery platform company focused on developing breakthrough immuno-oncology therapies, today announced it has appointed Jeffrey M. Goldberg as Chief Executive Officer and Director. He succeeds founding CEO, Christoph Westphal, M.D, Ph.D., who assumes the role of Chairman of the Board of Directors.
unknownx500
More posts by Park Square Executive Search
Recent posts from Park Square Executive Search
